Howard B Rosen is Director of ACELRX PHARMACEUTICALS INC. Currently has a direct ownership of 5,293 shares of ACRX, which is worth approximately $5,981. The most recent transaction as insider was on Oct 10, 2023, when has been sold 581 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 5.29K
0% 3M change
94.38% 12M change
Total Value Held $5,981

Howard B Rosen Transaction History

Date Transaction Value Shares Traded Shares Held Form
Oct 10 2023
BUY
Grant, award, or other acquisition
-
581 Added 9.89%
5,293 Common Stock
Jul 15 2022
BUY
Grant, award, or other acquisition
-
15,500 Added 14.12%
94,250 Common Stock
Jun 17 2021
BUY
Grant, award, or other acquisition
-
10,000 Added 11.27%
78,750 Common Stock

Also insider at

KALA
Kala Pharmaceuticals, Inc. Healthcare
HBR

Howard B Rosen

Director
Hayward, CA

Track Institutional and Insider Activities on ACRX

Follow ACELRX PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACRX shares.

Notify only if

Insider Trading

Get notified when an Acelrx Pharmaceuticals Inc insider buys or sells ACRX shares.

Notify only if

News

Receive news related to ACELRX PHARMACEUTICALS INC

Track Activities on ACRX